Personal tools
Log in

Skip to content. | Skip to navigation

Sections
Document Actions
enGINe Newsletter

Subscribe here to the enGINe Newsletter.

Search
Documents in the library
Positronen-Emissions-Tomograph...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Positronen-Emissions-Tomographie (PET) bei Ovarialkarzinom

Status:
Published
Date of publication:
Mar 27, 2012
Belimumab - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Belimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Fampridin - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Fampridin - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Ipilimumab - Nutzenbewertung g...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Ipilimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 27, 2012
Evidence-based care guideline ...

AHRQ (US) - Agency for Healthcare Research and Quality

Evidence-based care guideline for prevention and management of acute gastroenteritis (AGE) in children aged 2 months to 18 years. Cincinnati Children's Hospital Medical Center. NGC:008846

Status:
Published
Date of publication:
Dec 21, 2011
More guidelines
 

Chair's column July 2010

Sara Twaddle

Dear Colleagues,

Greetings from a sunny Scotland!  I thought I would take this opportunity to update you on some of the activities of the G-I-N Board over the last few months.

We had a very productive meeting in Paris at the end of March where we looked at all aspects of G-I-N’s work and where we go from here.  Following that meeting we have developed and refined our strategic plan for the next three years and that is currently out for consultation with the members of our working groups and sub-committees. Once we have refined the plan in the light of these comments we will share this with all our members and debate this at our Annual General meeting in Chicago at the end of August.

Another discussion in Paris was concerned with current issues in the guideline world. With Board members from five continents we were able to identify issues from almost the whole world and, perhaps not surprisingly, they were very similar. Key issues of relevance to G-I-N included:

  • Is there a future for clinical guidelines?
  • Implementation
  • Collaboration
  • Electronic decision support
  • Conflicts of interest
  • Adaptation
  • Increasing  interest from policy makers
  • Accreditation of others’ guidelines
  • Special problems of low/middle income countries.

Such similar problems once again reinforce the need to work collaboratively and we need to ensure that G-I-N’s activities help us to find joint solutions. One obvious way that we can do this is via the networking opportunities at our annual conference - don’t forget that the Early Bird Registration finishes on 24 June. I look forward to seeing you all there.

 

Kind regards,

Sara Twaddle, Chair of G-I-N

Page last updated: Jul 07, 2010

Bookmark & Share:

  • Facebook
  • Google Bookmarks
  • Twitter

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.